Publicaciones en las que colabora con José Luis de Pablos (33)

2021

  1. One-year, efficacy and safety open label study, with a single injection of a new hyaluronan for knee oa: The soya trial

    Journal of Pain Research, Vol. 14, pp. 2229-2237

2020

  1. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: A multicentric matched cohort study

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 12, pp. 1544-1549

  2. Erratum corrige: "Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study". J.L. Pablos et al

    Clinical and experimental rheumatology

  3. IL6/sIL6R regulates TNFα-inflammatory response in synovial fibroblasts through modulation of transcriptional and post-transcriptional mechanisms

    BMC Molecular and Cell Biology, Vol. 21, Núm. 1

  4. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 9, pp. 1170-1173

2019

  1. Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study

    Clinical and experimental rheumatology, Vol. 37, Núm. 3, pp. 437-444

  2. Senescent synovial fibroblasts accumulate prematurely in rheumatoid arthritis tissues and display an enhanced inflammatory phenotype

    Immunity and Ageing, Vol. 16, Núm. 1

2017

  1. Exploring the remission concept in rheumatoid arthritis with patients and rheumatologists: Time for a new approach?

    Clinical and Experimental Rheumatology, Vol. 35, Núm. 5, pp. 816-822

  2. Hif-1α Knockdown Reduces Glycolytic Metabolism and Induces Cell Death of Human Synovial Fibroblasts under Normoxic Conditions

    Scientific Reports, Vol. 7, Núm. 1

2014

  1. Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: Case-control study

    Arthritis Research and Therapy, Vol. 16, Núm. 1

2012

  1. Transcriptome analysis reveals specific changes in osteoarthritis synovial fibroblasts

    Annals of the Rheumatic Diseases, Vol. 71, Núm. 2, pp. 275-280

2010

  1. The transcriptional response of normal and rheumatoid arthritis synovial fibroblasts to hypoxia

    Arthritis Care and Research, Vol. 62, Núm. 12, pp. 3584-3594

2009

  1. Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-κB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility

    Arthritis Research and Therapy, Vol. 11, Núm. 2

  2. Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, Eotaxin-3, and MHC2TA

    Journal of Rheumatology, Vol. 36, Núm. 8, pp. 1590-1595

  3. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors

    Arthritis and Rheumatism, Vol. 60, Núm. 9, pp. 2558-2564

2008

  1. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 5, pp. 631-637

2006

  1. SUMO4 and MAP3K7IP2 single nucleotide polymorphisms and susceptibility to rheumatoid arthritis

    Journal of Rheumatology, Vol. 33, Núm. 6, pp. 1048-1051

2005

  1. Polymorphism of the interleukin-1 receptor antagonist gene: A factor in susceptibility to rheumatoid arthritis in a Spanish population

    Arthritis and Rheumatism, Vol. 52, Núm. 10, pp. 3015-3019

2003

  1. CARD15/NOD2 analysis in rheumatoid arthritis susceptibility

    Rheumatology, Vol. 42, Núm. 11, pp. 1380-1382

  2. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis

    Journal of Immunology, Vol. 170, Núm. 4, pp. 2147-2152